Center for Breakthrough Medicines

📍 King of Prussia, United States🗓 Founded 2020👥 351 employees💰 Last funded 2019
Biotechnology Research🌐 breakthroughmedicines.com
Website LinkedIn
Center for Breakthrough Medicines is an innovative cell and gene therapy focused contract development and manufacturing organization located in the heart of “Cellicon Valley.” CBM’s integrated and comprehensive service offering provides a one-source solution to accelerate speed to market for advanced therapies. A client-driven approach coupled with a patient-centric culture delivers high quality and reliable process and analytical development, viral vector manufacturing, GMP testing, cell therapy bioprocessing, plasmid production, and cell banking services for a full product’s life cycle.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Center for Breakthrough Medicines?
Center for Breakthrough Medicines has 1 investor on record on gritt.io, including 1 early-stage backers.
When did Center for Breakthrough Medicines last raise funding?
The most recent investment in Center for Breakthrough Medicines recorded on gritt.io was in 2019.
When was Center for Breakthrough Medicines founded?
Center for Breakthrough Medicines was founded in 2020.
What industry is Center for Breakthrough Medicines in?
Center for Breakthrough Medicines operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Center for Breakthrough Medicines based?
Center for Breakthrough Medicines is headquartered in King of Prussia, United States.